Veradermics shares surge as hair loss drug trial meets primary endpoint
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
In phase 2/3 clinical trials targeting male pattern baldness, the oral sustained-release minoxidil preparation VDPHL01 achieved all primary and key secondary endpoints with extremely high statistical significance. Read more
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
AI hardware myth cools off? Dell (DELL.US) plunges 11%, Barclays slashes ratings for the three server giants
Dell plummeted 11% on Wednesday, dragging down data center equipment stocks. Barclays downgraded Dell, Hewlett Packard Enterprise, and NetApp to "hold."
智通财经•2026/10/15 00:46
Yemen's Houthis vow more attacks on Saudi airports, oil facilities
FXStreet•2026/10/15 00:21
Yen slips to a three-week low on US CPI, then recovers it all
FXStreet•2026/10/15 00:15
Crypto prices
More
Bitcoin
BTC
$81,411.45
-2.54%
Ethereum
ETH
$2,414.83
-3.95%
Tether USDt
USDT
$0.9988
-0.03%
BNB
BNB
$729.23
-2.08%
XRP
XRP
$1.33
-3.54%
USDC
USDC
$0.9999
+0.02%
Solana
SOL
$104.29
-3.28%
TRON
TRX
$0.3317
+1.43%
Hyperliquid
HYPE
$80.77
-2.11%
Zcash
ZEC
$1,138.73
-8.43%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now